Jason Haas - 12 Oct 2021 Form 3 Insider Report for Syros Pharmaceuticals, Inc. (SYRS)

Role: Chief Financial Officer
Signature: /s/ Jason Haas
Issuer symbol: SYRS
Transactions as of: 12 Oct 2021
Net transactions value: $0
Form type: 3
Filing time: 13 Oct 2021, 16:04:37 UTC
Next filing: 17 Feb 2022
SEC: View on sec.gov

No securities are beneficially owned.

Remarks:

No securities are beneficially owned. Exhibit 24: Power of Attorney